Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) Must Be Frustrated After Market Cap Dropped US$69m Since Recent Purchases
Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) Must Be Frustrated After Market Cap Dropped US$69m Since Recent Purchases
Key Insights
主要见解
- Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable ownership
- Robert Duggan owns 70% of the company
- Insiders have bought recently
- 内部人士似乎对Pulse Biosciences的增长有着旺盛的兴趣,这可以从他们的大量拥有股权中看出
- Robert Duggan拥有该公司的70%股权
- 内部人士最近购买了股票。
To get a sense of who is truly in control of Pulse Biosciences, Inc. (NASDAQ:PLSE), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are individual insiders with 71% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
要了解Pulse Biosciences, Inc. (NASDAQ:PLSE)真正掌控权的实际情况,了解该业务的所有权结构非常重要。持有71%股份的是个体内部人员,是持有最大股份的人。换句话说,该组面临着最高的上行潜力(或下行风险)。
Notably, insiders have bought shares recently. However, with shares price down 7.5% last week, they must be disappointed.
需要注意的是,内部人士最近购买了股票。然而,股价上周下跌了7.5%,他们必须感到失望。
Let's delve deeper into each type of owner of Pulse Biosciences, beginning with the chart below.
让我们深入探讨Pulse Biosciences的每种所有者类型,从下面的图开始。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-275af4fe0f26b9e87f960222c3617b31-0-9cc6096eefbb5501ae58f0883676442b.png/big)
What Does The Institutional Ownership Tell Us About Pulse Biosciences?
机构持有情况能告诉我们什么关于Pulse Biosciences?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
机构通常在向自己的投资者报告时会针对一个基准进行衡量,因此一旦某只股票被纳入主要指数,他们通常会更加热衷于该股票。我们预计大多数公司都会有一些机构在登记簿上,尤其是那些正在增长的公司。
As you can see, institutional investors have a fair amount of stake in Pulse Biosciences. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Pulse Biosciences, (below). Of course, keep in mind that there are other factors to consider, too.
正如您所看到的,机构投资者在Pulse Biosciences中拥有相当大的股份。这可能表示在投资社区中,该公司具有一定的信誉度。然而,最好不要仅仅依赖机构投资者所带来的所谓认可。他们也会犯错。如果两个大型机构投资者同时试图退出某个股票,通常会看到股价大幅下跌。因此,值得检查下面Pulse Biosciences的过往收益历程。当然,还要记住还有其他因素需要考虑。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240806/0-275af4fe0f26b9e87f960222c3617b31-1-4d8a9fd52095d297c5bce9a488b7bc71.png/big)
We note that hedge funds don't have a meaningful investment in Pulse Biosciences. From our data, we infer that the largest shareholder is Robert Duggan (who also holds the title of Top Key Executive) with 70% of shares outstanding. Its usually considered a good sign when insiders own a significant number of shares in the company, and in this case, we're glad to see a company insider play the role of a key stakeholder. In comparison, the second and third largest shareholders hold about 1.7% and 1.4% of the stock.
我们注意到,对于Pulse Biosciences,对冲基金没有实质性的投资。从我们的数据中,我们推断最大的股东是Robert Duggan(也是最高关键执行官)拥有70%的流通股。当内部人员拥有公司的大量股票时,通常被视为一个很好的迹象,在这种情况下,我们很高兴看到公司内部人员担任重要的利益相关者的角色。相比之下,第二和第三大股东持有约1.7%和1.4%的股份。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.
虽然研究公司的机构所有权数据是有意义的,但考虑到分析师的看法,了解风向也是有意义的。我们的信息表明,该股票没有任何分析师的覆盖,因此它可能鲜为人知。
Insider Ownership Of Pulse Biosciences
Pulse Biosciences的内部股权
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
虽然“内部人士”的明确定义具有主观性,但几乎所有人都认为董事会成员是内部人士。公司管理业务,但首席执行官即使是董事会成员,也要向董事会负责。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常认为内部人士持股是一件好事。但是,在某些情况下,它会使其他股东更难以对董事会的决定进行问责。
It seems that insiders own more than half the Pulse Biosciences, Inc. stock. This gives them a lot of power. Given it has a market cap of US$908m, that means they have US$648m worth of shares. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.
看起来内部人员持有了半数以上的Pulse Biosciences, Inc.股票。这给了他们很大的权力。鉴于其市值为US$90800万,这意味着他们持有价值US$64800万的股票。看到这种投资水平是好的。您可以在这里查看这些内部人员最近是否有购买。
General Public Ownership
一般大众所有权
With a 20% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Pulse Biosciences. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
占有20%的大众股东,主要由个人投资者组成,对Pulse Biosciences有一定的影响力。尽管占有相当大的股份,但如果决策与其他大股东无关,则可能无法改变公司政策。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Pulse Biosciences has 4 warning signs (and 3 which can't be ignored) we think you should know about.
我认为了解哪些人拥有公司非常有趣。但要真正获得洞察力,我们还需要考虑其他信息。例如,冒险 - 我们认为Pulse Biosciences有4个警告信号(以及3个不能被忽视的信号)。
If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.
如果您更喜欢核对具有潜在优越财务状况的其他公司,则不要错过此免费的备有强大财务数据支持的有趣公司列表。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。